In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19Mahmoud Elkazzaz, Israa M. Shamkh, Dalia Hamza et al.|Vaccines|2022Cited by 17
In silico discovery of GPCRSs and GnRHRs as Novel SARS-CoV-2 binding receptors, the Scientific Breakthrough that could explain the observed High cortisol, Appetite loss, Ansomnia and Hypogonadism, as well as Hypothyroidism, Retinol deficiency and menstrual disturbances among SARS-COV-2 patients.Mahmoud Elkazzaz, Tamer Haydara, Amr Ahmed et al.|Research Square|2021Cited by 5
Discovery of the Retinol STRA6 Receptor as a Novel Binding Receptor for SARS-CoV-2 in COVID-19: In Silico Research.Mahmoud Elkazzaz, Amr Ahmed, Israa M. Shamkh et al.|Research Square|2021Cited by 5
STRA6, as A Novel Binding Receptor of COVID-19, A Breakthrough That could Explain COVID-19 Symptoms with Unknown Aetiology.Mahmoud Elkazzaz, Amr Ahmed, Tamer Haydara et al.|Research Square|2021Cited by 4
STRA6 (vitamin A receptor), as a Novel binding receptor of COVID-19 (A breakthrough)Mahmoud Elkazzaz, Amr Ahmed, Tamer Haydara et al.|Research Square|2021Cited by 3